These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 10408728

  • 1. Influence of amino acid substitutions on antigenicity of immunodominant regions of the HTLV type I envelope surface gylcoprotein: a study using monoclonal antibodies raised against relevant peptides.
    Londos-Gagliardi D, Jauvin V, Armengaut MH, Astier-Gin T, Goetz M, Huet S, Guillemain BJ.
    AIDS Res Hum Retroviruses; 1999 Jul 01; 15(10):909-20. PubMed ID: 10408728
    [Abstract] [Full Text] [Related]

  • 2. The humoral immune response to human T-cell lymphotropic virus type 1 envelope glycoprotein gp46 is directed primarily against conformational epitopes.
    Hadlock KG, Rowe J, Foung SK.
    J Virol; 1999 Feb 01; 73(2):1205-12. PubMed ID: 9882322
    [Abstract] [Full Text] [Related]

  • 3. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
    Palker TJ, Tanner ME, Scearce RM, Streilein RD, Clark ME, Haynes BF.
    J Immunol; 1989 Feb 01; 142(3):971-8. PubMed ID: 2563272
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity of variable regions of the surface envelope glycoprotein of HTLV type I and identification of new major epitopes in the 239-261 region.
    Londos-Gagliardi D, Dalibart R, Geoffre S, Dalbon P, Pouliquen JF, Georges-Courbot MC, Sainte-Foie S, Hajjar C, Georges AJ, Moreau JP, Guillemain B.
    AIDS Res Hum Retroviruses; 1996 Jul 01; 12(10):941-50. PubMed ID: 8798979
    [Abstract] [Full Text] [Related]

  • 5. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine.
    Baba E, Nakamura M, Tanaka Y, Kuroki M, Itoyama Y, Nakano S, Niho Y.
    J Immunol; 1993 Jul 15; 151(2):1013-24. PubMed ID: 7687611
    [Abstract] [Full Text] [Related]

  • 6. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
    Baba E, Nakamura M, Ohkuma K, Kira J, Tanaka Y, Nakano S, Niho Y.
    J Immunol; 1995 Jan 01; 154(1):399-412. PubMed ID: 7527817
    [Abstract] [Full Text] [Related]

  • 7. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
    Kuroki M, Nakamura M, Itoyama Y, Tanaka Y, Shiraki H, Baba E, Esaki T, Tatsumoto T, Nagafuchi S, Nakano S.
    J Immunol; 1992 Aug 01; 149(3):940-8. PubMed ID: 1378869
    [Abstract] [Full Text] [Related]

  • 8. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
    Hernández M, Selles ME, Pozo Peña L, Gómez I, Melchor A.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):1085-8. PubMed ID: 11027594
    [Abstract] [Full Text] [Related]

  • 9. Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46.
    Lairmore MD, Rudolph DL, Roberts BD, Dezzutti CS, Lal RB.
    Cancer Lett; 1992 Sep 14; 66(1):11-20. PubMed ID: 1360328
    [Abstract] [Full Text] [Related]

  • 10. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides.
    Horal P, Hall WW, Svennerholm B, Lycke J, Jeansson S, Rymo L, Kaplan MH, Vahlne A.
    Proc Natl Acad Sci U S A; 1991 Jul 01; 88(13):5754-8. PubMed ID: 1712105
    [Abstract] [Full Text] [Related]

  • 11. Antibodies directed against a variable and neutralizable region of the HTLV-I envelope surface glycoprotein.
    Londos-Gagliardi D, Armengaud MH, Freund F, Dalibart R, Moze E, Huet S, Legrand E, Guillemain BJ.
    Leukemia; 1997 Apr 01; 11 Suppl 3():38-41. PubMed ID: 9209290
    [Abstract] [Full Text] [Related]

  • 12. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
    Tallet B, Astier-Gin T, Moynet D, Londos-Gagliardi D, Guillemain B.
    AIDS Res Hum Retroviruses; 2001 Mar 01; 17(4):337-48. PubMed ID: 11242520
    [Abstract] [Full Text] [Related]

  • 13. Epitope mapping of human monoclonal antibodies recognizing conformational epitopes within HTLV type 1 gp46, employing HTLV type 1/2 envelope chimeras.
    Hadlock KG, Yang Q, Rowe J, Foung SK.
    AIDS Res Hum Retroviruses; 2002 Jan 01; 18(1):57-70. PubMed ID: 11804557
    [Abstract] [Full Text] [Related]

  • 14. Study of the peptide length and amino acid specific substitution in the antigenic activity of the chimeric synthetic peptides, containing the p19 core and gp46 envelope proteins of the HTLV-I virus.
    Marin MH, Rodríguez-Tanty C, Higginson-Clarke D, Bocalandro YM, Peña LP.
    Biochem Biophys Res Commun; 2005 Oct 28; 336(3):983-6. PubMed ID: 16157308
    [Abstract] [Full Text] [Related]

  • 15. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization.
    Tanaka Y, Zeng L, Shiraki H, Shida H, Tozawa H.
    J Immunol; 1991 Jul 01; 147(1):354-60. PubMed ID: 1711082
    [Abstract] [Full Text] [Related]

  • 16. Cervicovaginal synthesis of IgG antibodies to the immunodominant 175-199 domain of the surface glycoprotein gp46 of human T-cell leukemia virus type I.
    Bélec L, Georges-Courbot MC, Georges A, Mohamed AS, Londos-Gagliardi D, Hallouin MC, Hocini H, Guillemain B.
    J Med Virol; 1996 Sep 01; 50(1):42-9. PubMed ID: 8890040
    [Abstract] [Full Text] [Related]

  • 17. Characterization of monoclonal antibodies directed against the gp46 of human T-cell leukemia virus type I.
    Edouard E, Legrand E, Astier-Gin T, Dalibart R, Geoffre S, Dalbon P, Guillemain B, Londos-Gagliardi D.
    Leukemia; 1994 Apr 01; 8 Suppl 1():S60-4. PubMed ID: 7512182
    [Abstract] [Full Text] [Related]

  • 18. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
    Hernández Marin M, Castellanos Pentón P, Márquez Bocalandro Y, Pozo Peña L, Díaz Navarro J, González López LJ.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):1-6. PubMed ID: 11708767
    [Abstract] [Full Text] [Related]

  • 19. Humoral responses to the immunodominant gag and env epitopes of human T-lymphotropic virus type I among Melanesians.
    Lal RB, Rudolph DL, Nerurkar VR, Yanagihara R.
    Viral Immunol; 1992 Nov 23; 5(4):265-72. PubMed ID: 1282011
    [Abstract] [Full Text] [Related]

  • 20. Generation and characterization of monoclonal antibodies against multiple epitopes on the C-terminal half of envelope gp46 of human T-cell leukemia virus type-I (HTLV-I).
    Tanaka Y, Yasumoto M, Nyunoya H, Ogura T, Kikuchi M, Shimotohno K, Shiraki H, Kuroda N, Shida H, Tozawa H.
    Int J Cancer; 1990 Oct 15; 46(4):675-81. PubMed ID: 1698731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.